Bruker
Bruker Makes Majority Investment in Mass Spec Dx Firm
Bruker said the investment will increase its capabilities in small molecule clinical diagnostics, including in therapeutic drug monitoring and other applications.
At ESCMID, Expert Extols New RNA Biomarker, EliTech Assay for Managing CMV Infection Post-Transplant
Premium
The RNA biomarker for monitoring cytomegalovirus infection and therapy efficacy in immunocompromised patients can be quantified with a PCR kit from Bruker's EliTechGroup.
PrognomiQ Closes $34M Series D Round
The company said it will use the funding for development of its blood-based early detection test for lung cancer, which it plans to offer initially as an LDT and then as an IVD.
EliTechGroup Gets IVDR Class C Certification for Three PCR-Based Assays
The French molecular diagnostics and reagent company was recently acquired by Bruker for nearly $930 million in cash.
In Brief This Week: Bruker; BD; Immunovia; American Cancer Society, Color Health
News items for the week of April 29, 2024.
Dec 27, 2023
Bruker to Acquire EliTechGroup, Phasefocus
Mar 15, 2022
PrognomiQ Closes $46M Financing Round
Feb 11, 2022
Apr 14, 2021
Sep 26, 2019